Cohort profile: the WHO Child Mortality Risk Stratification Multi-Country Pooled Cohort (WHO-CMRS) to identify

Catherine Schwinger1, Siri Kaldenbach2, James A Berkley3,4

  • 1Department for Global Public Health and Primary Care, Centre for International Health, Universitetet i Bergen, Bergen, Norway c.schwinger@uib.no.

BMJ Open
|November 29, 2024
PubMed

Insights

This study pooled data from over 75,000 children to analyze child mortality risks and predictive factors. Findings will inform global health guidelines for child survival and growth strategies.

Area of Science:

  • Global Health
  • Pediatric Epidemiology
  • Child Survival Research

Background:

  • Child mortality remains a significant global health challenge, particularly in low- and middle-income countries.
  • Accurate risk stratification is crucial for effective interventions and resource allocation.

Purpose of the Study:

  • To detail a large, pooled dataset for analyzing mortality risks in children under 59 months.
  • To evaluate the predictive performance of common risk exposures on child outcomes.
  • To inform global guidelines and research agendas for child survival.

Main Methods:

  • Pooled data from 33 longitudinal studies across 17 low- and middle-income countries.
  • Included 75,287 children aged 0-5 years, with a median follow-up of 15 months.
  • Collected data on birth characteristics, anthropometry, feeding practices, and common childhood illnesses.

Main Results:

  • The pooled sample had 2805 (3.7%) deaths.
  • 14% low birth weight, 14% preterm birth, 33% stunted, 24% wasted, 35% underweight.
  • Breastfeeding decreased from 99% at <6 months to 77% at 12-23 months.

Conclusions:

  • The comprehensive dataset enables robust estimation of mortality risks and predictive factors.
  • Findings will contribute to evidence-based global health strategies for child survival.
  • Further research will refine risk stratification and inform clinical management tools.
Abstract

Related Concept Videos

Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
63
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
152
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
83
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
11.9K
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
100